ArticleRMD open2021

Tofacitinib versus tocilizumab in the treatment of biological-naïve or previous biological-failure patients with methotrexate-refractory active rheumatoid arthritis.

Shunsuke Mori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.